Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-03

Clinical Trial Update: Pediatric Spinal Muscular Atrophy (SMA) China Registry

View source ↗

Summary

Biogen-sponsored pediatric spinal muscular atrophy registry in China is currently active and not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Biogen | Conditions: Muscular Atrophy, Spinal | Status: ACTIVE_NOT_RECRUITING